ADULT B ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for ADULT B ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ADULT B ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ADULT B ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo tackles tough leukemias in early trial
Disease control CompletedThis early-phase study tested a combination of two drugs—veliparib and temozolomide—in 66 adults with acute leukemias that had come back or not responded to standard treatment. The goal was to find the safest dose and see how well the combo worked. Veliparib blocks a repair enzym…
Matched conditions: ADULT B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:05 UTC
-
New drug combo shows promise for Hard-to-Treat leukemia
Disease control CompletedThis study tested a combination of two drugs, ibrutinib and blinatumomab, in 19 adults with B-cell acute lymphoblastic leukemia that had returned or stopped responding to treatment. The goal was to see how well the drugs worked together to stop cancer growth. The study is complet…
Matched conditions: ADULT B ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 19, 2026 12:01 UTC